2019
DOI: 10.1128/jcm.00886-19
|View full text |Cite
|
Sign up to set email alerts
|

Multicenter Clinical Evaluation of a Novel Multiplex Real-Time PCR (qPCR) Assay for Detection of Fluoroquinolone Resistance in Mycoplasma genitalium

Abstract: Mycoplasma genitalium causes a common sexually transmitted infection with a marked propensity to develop antimicrobial resistance. As few treatment options exist, this poses significant challenges to clinicians. Recent diagnostic advances have resulted in tests that report the simultaneous detection of M. genitalium and any resistance to macrolides, the first-line treatment. This allows for therapy to be tailored to the individual, thereby optimizing treatment outcomes.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
22
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
8
1

Relationship

3
6

Authors

Journals

citations
Cited by 26 publications
(23 citation statements)
references
References 19 publications
0
22
1
Order By: Relevance
“…Mutants were then confirmed by sequencing of the 23S rRNA gene using a previously described methodology (7). Fluoroquinolone resistance-associated parC mutations were also retrospectively studied as previously described (19). Positive primary samples were stored at -20°C and sent to the Statens Serum Institut in Copenhagen, Denmark, for subsequent analyses.…”
Section: Methodsmentioning
confidence: 99%
“…Mutants were then confirmed by sequencing of the 23S rRNA gene using a previously described methodology (7). Fluoroquinolone resistance-associated parC mutations were also retrospectively studied as previously described (19). Positive primary samples were stored at -20°C and sent to the Statens Serum Institut in Copenhagen, Denmark, for subsequent analyses.…”
Section: Methodsmentioning
confidence: 99%
“…In contrast to the commercial availability of several assays detecting macrolide RAMs in Mg, assays detecting fluoroquinolone RAMs are sparse. [25] There are different mutations in the quinolone resistance determining region of the parC and gyrA gene that have been associated with fluoroquinolone resistance. [2528] In our study, only seven samples presented with a gyrA mutation and five of them coincided with a parC mutation at amino acid position 83, which seems to lead to high level resistance.…”
Section: Discussionmentioning
confidence: 99%
“…[25] There are different mutations in the quinolone resistance determining region of the parC and gyrA gene that have been associated with fluoroquinolone resistance. [2528] In our study, only seven samples presented with a gyrA mutation and five of them coincided with a parC mutation at amino acid position 83, which seems to lead to high level resistance. [29] The two other alterations found (M69I and A79V) have not yet been correlated with clinical resistance.…”
Section: Discussionmentioning
confidence: 99%
“…Quantitative PCR-based assays are generally quicker, more convenient, and cheaper than Sanger sequencing. We previously evaluated the test MG+ parC (beta) (SpeeDx, Sydney, Australia) that detects M. genitalium plus five parC SNPs (excluding G248A/S83N) [ 15 ]. In this study we evaluate the performance of the revised assay, MG+ parC (beta2), that detects the six above mentioned SNPs in parC ( Table 1 ).…”
Section: Introductionmentioning
confidence: 99%